Our View

中文

Our View is our own analysis of a company: the argument, the facts it rests on, the other side, and scenarios for 2030 with probabilities from our model, all built on stated assumptions (how to read the scenario numbers). It is opinion, not investment advice: we never tell you to buy or sell a stock. Don't see a stock? Request it →

  • MRNA OUR VIEW · OPINION

    Moderna: what today's price assumes about its cancer platform

    Our analysis of Moderna after its cancer-vaccine success and Analyst Day: what the price assumes about its platform, and what 50,000 simulations say about end-2030 value.

    15 min read · Moderna